B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Hesperadin

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Hesperadin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lorlatinib
5 shared targets
upadacitinib
5 shared targets
entrectinib
4 shared targets
reversine
3 shared targets
azd
5 shared targets
amg
6 shared targets
asp
6 shared targets
bms
8 shared targets
brigatinib
8 shared targets
pf
9 shared targets
Loading evidence profile...

This evidence profile for Hesperadin is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.